Published in Journal of the American College of Surgeons · View the paper (DOI)
A recent study found that microRNA-145 can identify breast cancer patients at lower risk of recurrence and those who may need additional therapy. The biomarker was measured in patients' blood samples during chemotherapy and predicted long-term oncological outcomes.
Coverage from 2 institutions